| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 15,329,900 | 13,789,700 | 12,237,700 | | Cost of Revenue | 6,703,500 | 6,042,300 | 5,536,100 | | | Gross Profit | 8,626,400 | 7,747,400 | 6,701,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,445,300 | 4,973,000 | 4,355,200 | | Non Recurring | 24,000 | 39,700 | 106,600 | | Others | 18,800 | 18,200 | 16,300 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,138,300 | 2,716,500 | 2,223,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (31,100) | 10,000 | (1,000) | | Earnings Before Interest And Taxes | 3,030,700 | 2,663,100 | 2,168,400 | | Interest Expense | 105,600 | 166,600 | 166,600 | | Income Before Tax | 2,925,100 | 2,496,500 | 2,001,800 | | Income Tax Expense | 967,900 | 759,100 | 648,400 | | Minority Interest | (80,300) | (67,100) | (57,500) | | | | Net Income From Continuing Ops | 1,957,200 | 1,737,400 | 1,353,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,957,200 | 1,737,400 | 1,353,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,957,200 | $1,737,400 | $1,353,400 |
|
1.48% Nasdaq 
Income Statement
